Founders Capital Management (Connecticut)’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,040	Closed	-$211K	–	78
2023 Q1	$211K	Hold	3,040	–	–	0.05%	70
2022 Q4	$219K	Hold	3,040	–	–	0.06%	69
2022 Q3	$216K	Hold	3,040	–	–	0.06%	66
2022 Q2	$234K	Hold	3,040	–	–	0.06%	65
2022 Q1	$222K	Buy	+3,040	New	+$204K	0.05%	67
2021 Q3	–	Sell	-3,525	Closed	-$236K	–	65
2021 Q2	$236K	Sell	3,525 -915	-21%	-$59.7K	0.06%	66
2021 Q1	$280K	Buy	4,440 +1,000	+29%	+$62.2K	0.07%	66
2020 Q4	$213K	Buy	+3,440	New	+$212K	0.06%	66
2018 Q4	–	Sell	-5,399	Closed	-$341K	–	52
2018 Q3	$341K	Sell	5,399 -4	-0.1%	-$237	0.14%	44
2018 Q2	$299K	Hold	5,403	–	–	0.14%	43
2018 Q1	$335K	Buy	5,403 +1,280	+31%	+$82.3K	0.15%	41
2017 Q4	$253K	Hold	4,123	–	–	0.11%	48
2017 Q3	$263K	Buy	4,123 +26	+0.6%	+$1.52K	0.13%	49
2017 Q2	$230K	Hold	4,097	–	–	0.11%	51
2017 Q1	$223K	Buy	4,097 +29	+0.7%	+$1.59K	0.11%	51
2016 Q4	$238K	Buy	4,068 +28	+0.7%	+$1.53K	0.13%	49
2016 Q3	$218K	Buy	4,040 +18	+0.4%	+$1.16K	0.12%	50
2016 Q2	$296K	Buy	4,022 +19	+0.5%	+$1.34K	0.17%	43
2016 Q1	$256K	Buy	4,003 +24	+0.6%	+$1.51K	0.15%	45
2015 Q4	$274K	Sell	3,979 -1,455	-27%	-$96.2K	0.17%	45
2015 Q3	$322K	Buy	5,434 +21	+0.4%	+$1.33K	0.21%	42
2015 Q2	$360K	Buy	5,413 +20	+0.4%	+$1.32K	0.22%	41
2015 Q1	$348K	Buy	+5,393	New	+$338K	0.21%	40